Company / SG&A Expense
PRECISION BIOSCIENCES INC SG&A Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$35.3M
FY2025
5-year range
$35.3M / $41.3M
FY2021-FY2025
Trend
-9.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $41M to $35M over the past 2 years.
Based on SEC 10-K filings.
$35M in FY2025 with a 5-year CAGR of +5.5%.
Improved from $41M to $35M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -3.8%
- 5-Year CAGR
- +5.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +5.5%, indicating consistent growth.
- In FY2025, sg&a expense decreased 9.7% year-over-year.
- Peak sg&a expense was recorded in FY2023.
- Lowest sg&a expense in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $35.3M | -9.7% |
| FY2024 | $39.1M | -5.3% |
| FY2023 | $41.3M | +4.1% |
| FY2022 | $39.7M | +10.0% |
| FY2021 | $36.1M | +33.4% |
| FY2020 | $27.0M | +97.7% |
| FY2019 | $13.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026